Bridge to life (BTL) is a multinational leading company that specializes in improving organ transplantation through licensing and developing new preservation solutions and technologies in addition to providing the highest quality of service to organ procurement organizations and transplant centers.
BTL has an exclusive trademark license from the Wisconsin Alumni Research Foundation (WARF) for the trademarks Belzer UW® and Belzer MPS®. In fact, WARF holds an equity position in Bridge to Life Ltd.
Dr. Belzer and the institution that developed the UW organ preservation solution, is still holds the “gold standard” in organ preservation, and the Main supplier for Belzer (UW ) solution in the world.
Bridge to Life established its European operation, Bridge to Life (Europe) Ltd. in 2012. Its Belzer UW® solutions are now sold, worldwide, in 34 countries.